At a glance
- Originator Pharmacia Corporation
- Class Antifibrinolytics; Cyclohexanecarboxylic acids; Small molecules
- Mechanism of Action Fibrinogen stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Menorrhagia
Most Recent Events
- 24 Dec 2008 Discontinued - Phase-II for Menorrhagia in Sweden (unspecified route)
- 05 Apr 2000 Pharmacia & Upjohn has merged with Monsanto to form Pharmacia Corporation
- 21 Sep 1995 Phase-II clinical trials for Menorrhagia in Sweden (unspecified route)